Table of Content
- Executive Summary
- UK Market Outlook
- Demand to side Trends
- Supply to side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- UK Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
- Historical Market Size Value (USD Million) Analysis, 2021 to 2025
- Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
- Y to o to Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- UK Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
- UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Therapeutic Area
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Therapeutic Area, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Therapeutic Area, 2026 to 2036
- Rare Diseases
- Anti-infective
- Anticancer
- Neurological
- Others
- Y to o to Y Growth Trend Analysis By Therapeutic Area, 2021 to 2025
- Absolute $ Opportunity Analysis By Therapeutic Area, 2026 to 2036
- UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Modality
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Modality, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Modality, 2026 to 2036
- Messenger RNA
- RNA Interference
- Antisense Therapy
- Oligonucleotide
- Y to o to Y Growth Trend Analysis By Modality, 2021 to 2025
- Absolute $ Opportunity Analysis By Modality, 2026 to 2036
- UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
- UK
- Market Attractiveness Analysis By Region
- UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- By Therapeutic Area
- By Modality
- Market Attractiveness Analysis
- By Country
- By Therapeutic Area
- By Modality
- Key Takeaways
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Therapeutic Area
- By Modality
- Competition Analysis
- Competition Deep Dive
- IQVIA Holdings Inc.
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- ICON plc
- Labcorp Holdings Inc.
- Charles River Laboratories International Inc.
- Parexel
- Syneos Health
- Medpace Holdings Inc.
- Pharmaceutical Product Development (PPD)
- Novotech Health Holdings Pte. Ltd.
- Veristat LLC
- IQVIA Holdings Inc.
- Competition Deep Dive
- Assumptions & Acronyms Used
- Research Methodology
List of Tables
- Table 1: UK Market Value (USD Million) Forecast by Region, 2021 to 2036
- Table 2: UK Market Value (USD Million) Forecast by Therapeutic Area, 2021 to 2036
- Table 3: UK Market Value (USD Million) Forecast by Modality, 2021 to 2036
- Table 4: UK Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 5: UK Market Value (USD Million) Forecast by Therapeutic Area, 2021 to 2036
- Table 6: UK Market Value (USD Million) Forecast by Modality, 2021 to 2036
List of Figures
- Figure 1: UK Market Pricing Analysis
- Figure 2: UK Market Value (USD Million) Forecast 2021 to 2036
- Figure 3: UK Market Value Share and BPS Analysis by Therapeutic Area, 2026 and 2036
- Figure 4: UK Market Y to o to Y Growth Comparison by Therapeutic Area, 2026 to 2036
- Figure 5: UK Market Attractiveness Analysis by Therapeutic Area
- Figure 6: UK Market Value Share and BPS Analysis by Modality, 2026 and 2036
- Figure 7: UK Market Y to o to Y Growth Comparison by Modality, 2026 to 2036
- Figure 8: UK Market Attractiveness Analysis by Modality
- Figure 9: UK Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
- Figure 10: UK Market Y to o to Y Growth Comparison by Region, 2026 to 2036
- Figure 11: UK Market Attractiveness Analysis by Region
- Figure 12: UK Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 13: UK Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 14: UK Market Value Share and BPS Analysis by Therapeutic Area, 2026 and 2036
- Figure 15: UK Market Y to o to Y Growth Comparison by Therapeutic Area, 2026 to 2036
- Figure 16: UK Market Attractiveness Analysis by Therapeutic Area
- Figure 17: UK Market Value Share and BPS Analysis by Modality, 2026 and 2036
- Figure 18: UK Market Y to o to Y Growth Comparison by Modality, 2026 to 2036
- Figure 19: UK Market Attractiveness Analysis by Modality
- Figure 20: UK Market - Tier Structure Analysis
- Figure 21: UK Market - Company Share Analysis
